Boditrectinib

• UNSPSC Description:

  Boditrectinib is a potent tyrosine kinase inhibitor. Boditrectinib serves as an antineoplastic agent. Boditrectinib is useful in the research of cancer, inflammation, neurodegenerative diseases and certain infectious diseases[1][2].

• Target Antigen:

  c-Met/HGFR

• Type:

  Reference compound

• Related Pathways:

  Protein Tyrosine Kinase/RTK

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/boditrectinib.html

• Solubility:

  10 mM in DMSO

• Smiles:

  FC1=C(C=C(C=C1)F)[C@@H]2N(C3=NC4=C(/C=C/C(N5CCNCC5)=O)C=NN4C=C3)CCC2

• Molecular Weight:

  438.47

• References & Citations:

  [1]Kim Moonsoo, et al. Preparation of fused ring heteroaryl compounds and their use as Trk inhibitors: United States, US20160168156. 2016-06-16.|[2]WHO Drug Information-World Health Organization (WHO).

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  1940165-80-9